HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Endometrial Cancer Intervention: Drug: HS-20089 Sponsor: Hansoh BioMedical R&D Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials